Kai-Fu Lee (Chairman and CEO of Sinovation Ventures)

Kai-Fu Lee

Chairman and CEO of Sinovation Ventures

Dr. Kai-Fu Lee is the Chairman and CEO of Sinovation Ventures (www.sinovationventures.com/) and President of Sinovation Venture’s Artificial Intelligence Institute. Sinovation Ventures, managing US$3 billion dual currency investment funds, is a leading venture capital firm focusing on developing the next generation of Chinese high-tech companies. Prior to founding Sinovation in 2009, Dr. Lee was the President of Google China, and senior executives at Microsoft, SGI, and Apple. Dr. Lee received his Bachelor degree from Computer Science from Columbia University, Ph.D. from Carnegie Mellon University, as well as Honorary Doctorate Degrees from both Carnegie Mellon and the City University of Hong Kong. He is the Co-Chair of Artificial Intelligence Council for World Economic Forum Center for the Fourth Industrial Revolution, Fellow of the Institute of Electrical and Electronics Engineers (IEEE), Times 100 in 2013, WIRED 25 Icons, Asian Business Leader 2018 by Asia House, author of the New York Times bestselling book AI Superpowers, and followed by over 50 million audience on social media.

Jinjian Zhang (Founding Partner at Vitalbridge Capital)

Jinjian Zhang

Founding Partner at Vitalbridge Capital

Jinjian Zhang is the Founding Partner of Vitalbridge Capital. He has over 12 years of private markets investment experience, across companies' life cycle and China's evolving market landscape. He is widely recognized by industry peers as "the most aggressive and influential AI investor" in China. His circulated investment methodology series, Signal and Noise, has been influential within the investment community. Jinjian was named to the Fortune China 40 Under 40 list in 2024 and was awarded "Best Asia Tech Fund Manager of the Year 2025" by SuperReturn & Pitchbook.. His representative investments include MiniMax(00100.HK), SUDO, LimX Dynamics, SpiritAI and HyperShell.

Jinjian founded Vitalbridge in 2019 and has established a thematic investment approach. This approach is highly selective, concentrated, and oriented towards long-term investments ahead of broad market consensus. Vitalbridge has become one of the most influential funds in the AI and embodied AI field in recent years.

Jinjian holds a Master’s degree from the National Laboratory of Fudan University, majoring in neural network.

Shirley Zhao (President of Astellas China)

Shirley Zhao

President of Astellas China

As the President of Astellas China, Shirley is a seasoned leader with over 30 years of experience in the pharmaceutical and biotech industries. Driven by the passion to bring the best healthcare to patients, she began her career as an obstetrician-gynecologist before moving into pharmaceutical commercial marketing and management roles.

With a track record of successfully driving brands to become market leaders in various therapeutic areas, Shirley brings extensive experience of developing corporate strategy, talent capability building and culture transforming & shaping. Prior to Astellas, Shirley has held various leadership positions in several multi-national and domestic innovative pharmaceutical companies, including VP and oncology BU head of Eli Lilly China, General Manager of Genzyme China, President of Allergan China, President of Bristol-Myers Squibb (BMS) China and General Manager of Cstone Greater China. She is also the first ever female General Manager of RDPAC, and the first Chinese Board Member of AmCham Shanghai.

The deep insight and high learning agility across companies and cultures, amidst the rapidly changing dynamics of China, brought numerous awards for Shirley including the Global President Award of BMS, the Global & APAC Best Brand Manager of Eli Lilly, the Best General Manager of Allergan International, and Women in ESG of sHero, etc. In 2025, Shirley was elected as the Executive Chairman of Alumni Association, Tongji University School of Medicine.

Shirley holds a Bachelor of Medicine degree from Tongji University School of Medicine in Shanghai and an MBA degree from the University of Leicester in the United Kingdom. She is an active co-founder of several women's leadership organizations and is a strong advocate for inclusion and diversity.

Sally Loh (President of Otis Greater China)

Sally Loh

President of Otis Greater China

Otis has a long and proud history in China – dating back more than 130 years. Today, the region is marked by rapid urbanization and the rise of the digital era, granting Otis new and ongoing opportunities to deliver innovative solutions to its customers.

As President of Otis China, Sally is responsible for evaluating and responding to these market dynamics to ensure continued growth and development of the Otis business in China, while focusing on the digital transformation across our Service, field installation, manufacturing and enterprise operations. Based in Shanghai, she leads her teams to develop and implement strategies that drive customer satisfaction and ensure the safe, comfortable and reliable riding experience they have come to expect from Otis.

Sally joined the Otis family more than two decades ago, and has held roles of increasing responsibility across Asia. She was named CFO of Otis China in 2015, COO in 2022, and President of our China region in 2023. She holds a bachelor’s degree in accountancy from Nanyang Technological University, Singapore and an MBA from the University of Manchester (UK).

Samantha Zhu (Chairperson and Market Unit Lead, Accenture Greater China at Accenture (China) Co., Ltd.)

Samantha Zhu

Chairperson and Market Unit Lead, Accenture Greater China at Accenture (China) Co., Ltd.

Samantha Zhu is Accenture’s Senior Managing Director, Chairperson and Market Unit Lead for Greater China, responsible for the company’s strategy, growth, and operations in the region. She leads a team of around 14,000 professionals that offer services across Strategy & Consulting, Technology, Operations, Industry X and Accenture Song to a wide variety of multinational and Chinese clients across industries.

Since joining Accenture in 1997, Samantha has held various leadership roles in Accenture Greater China, including Client Group Lead of Communications, Media & Technology, Operations Service Group, Human Capital and Diversity Lead, and the Corporate Citizenship Council Lead. Under her leadership, Accenture Greater China was certified as a Great Place to Work® for three years in a row since 2022.

Samantha has long been an advocate for responsible business and social impact, driving initiatives in women leadership, inclusion and diversity, and sustainability. She has been recognized as one of the most powerful women by Fortune China in 2022 and 2023 and as one of Forbes China’s 100 Power Businesswomen for three years as well. She sponsors Accenture’s engagement with the World Economic Forum on China’s energy transition and responsible AI.

Samantha holds a Bachelor of Arts from Fudan University and is based in Shanghai.

Dorothy Dong (China CEO / Chairman of Starr China)

Dorothy Dong

China CEO / Chairman of Starr China

Ms. Dorothy Ying Dong is the President of Starr International Investment Advisors (Asia) Limited and the Chairman of Starr Property & Casualty (China) Co., Ltd, responsible for the business operation, investment and development strategy in China for Starr Asia.

Ms. Dong Ying has been responsible for the establishment of Starr China Investment Platform since 2007 and focused on the healthcare investment fields. She has led the team and conducted investments in healthcare, technology, and insurance sectors, as well as Fund of Funds investments for more than 1.7 billion US dollars. Additionally, she has established a strong investment and industry ecosystem, resulting in excellent long-term performance returns through different economic cycles. Since 2014, she has served as Vice Chairman of Starr Insurance China and as the Chairman since 2020 after leading the acquisition of Dazhong Insurance.

Healthcare and technology are two of the fields in which Ms. Dong has extensive investments. Her investments include Techpool Bio, Buchang Pharma, Aidea Pharma, Gushengtang, Hanxi Hospitals, Nanyan Insurance, InnoCare, AkesoBio, Abbisko, Conmed, Boan Bio, Frontera, MegaRobo, Kuaishou, Kidswant, Huisuanzhang, JOVO Energy, and some other industry leaders, and establish close cooperative relationships with the entrepreneurial teams. As well as supporting and leading investments, Ms. Dong has also established strategic alliances with general partners to create a strong investment ecosystem, including Boyu, Yunfeng, Hew Horizon, Qiming, Sherpa, YuanBio, Long Hill, Hankang, Creacion, Quan, Eastern Bell, Sinovation, Ince, Gao Cheng, and some other leading funds.

Ms. Dong has over 25 years investment experiences. She has been working in many leading groups and serving as a member of the Bord of Directors or Advisory Board of many companies and investment funds. She has strong connections and resources in healthcare, insurance, finance, and technology fields, as well as related government authorities. Ms. Dong is the Founding Director and former Rotating Chairman of the China Medical and Health Industry Investment Forum of 50 (H50) and actively promoting the development of China's medical and health industry, as well as a Tutor of Tsinghua University School of Economics and Management (Tsinghua SEM) and an Executive Committee Member of China Children’s Development Fund, contributing to the progress of China's education and children's rights.

Prior to joining Starr, she served as a Vice President at AIG Global Investment Corp. (Shanghai) Ltd., a division of American International Group, Inc, focusing on private equity in the PRC, and as a Director at Anglo Chinese Finance Limited. She worked as an Analyst and Fund Manager for Atlas Fund at Rochdale Investment Management Company in New York. Prior to that, she worked for HSBC Corporate Finance (Asia) Limited and Credit Lyonnais Securities (Asia) Limited. Ms. Dong received Bachelor’s degree in law from Shanghai University (Fudan Sub-school) in the PRC, and MBA degree from McGill University, Canada. She was admitted as a CFA (Chartered Financial Analyst) and is a member of the Hong Kong Society of Financial Analysts and the CFA Institute.

Joanne Goh (Head of Business Execution at Citi)

Joanne Goh

Head of Business Execution at Citi

Joanne Goh is Head of Business Execution for Citi China, based in Shanghai.

In this role, Joanne is responsible for the execution of a wide spectrum of Citi China’s franchise management priorities. She is also focused on strengthening the firm’s risk management as well as legal entity governance.

Prior to assuming her current position, Joanne was the Head of Business Management of Corporate Banking in China, responsible for strategic priorities execution and in-business risk management of Corporates, Financial Institutions, Public Sector, and Global Subsidiaries groups. Before that, she was a China Market Specialist in Securities Services.

Joanne began her career at Citi as a Management Associate in Hong Kong in 2004, where she has held various roles in Operations, Financial Institutions, as well as Asia-Pacific and Hong Kong country Securities Services.

Joanne is passionate about promoting an inclusive culture and engagement. She is the Senior Sponsor for Citi China’s Families Matter Network and for CitiClub. She is also currently serving as the Vice Chair of the AmCham Shanghai’s Women’s Executive Network Committee. Joanne holds a Bachelor of Science degree and a Master of Chemical Engineering and Engineering Management degree from Cornell University.

Clark Gao (Co-founder of CREAO AI)

Clark Gao

Co-founder of CREAO AI

Clark Gao is Co-founder of CREAO AI, a Silicon Valley-based artificial intelligence company building the world's first conversational agent platform — where anyone can create, deploy, and orchestrate autonomous AI agents through natural language. Under Clark's go-to-market leadership, CREAO raised $30 million in funding and reached a $5 million annual revenue run rate within six months of product launch.

Clark's path to founding an AI company was anything but linear. After immigrating to Canada at fifteen, he worked as a busboy and sold Christmas trees to put himself through the University of Toronto. It was a neural networks course taught by Geoffrey Hinton, the godfather of deep learning, that changed his trajectory and set him on a decade-long journey in artificial intelligence and machine learning.

Clark began his career as a founding team member at InstartLogic in Silicon Valley, building machine learning tools at the frontier of web performance. He went on to lead neural network-driven patient selection at Blackthorn for clinical trials, and later joined LinkedIn as a data scientist. Seeking a deeper understanding of business at the intersection of technology and China's market, Clark pursued an MBA at CEIBS (China Europe International Business School) in Shanghai, during which he built and launched a social audio product amid the pandemic. He subsequently joined Tencent in a business strategy role before founding CREAO in 2024.

At CREAO, Clark leads with a thesis that the future of software is not tools people use, but agents people build — and that conversational creation will be the dominant interface for the next generation of AI-native companies. The company's platform spans four capability layers — assist, execute, create repeatable agents, and orchestrate — making CREAO one of the few products covering the full agent lifecycle.

Clark holds a Bachelor of Science in Statistics and Computer Science from the University of Toronto and an MBA from CEIBS. He is based in Hong Kong.

Ellen Wu (Senior HR Director of Microsoft (China) Ltd. Shanghai Branch)

Ellen Wu

Senior HR Director of Microsoft (China) Ltd. Shanghai Branch

Ellen has more than twenty five years of extensive human resources experience with proven track records in the areas of strategic business & people priority planning, leadership effectiveness and development, learning strategy, development framework, change management and organization development, talent development and executive and coaching, employee engagement and retention both at strategic and operational levels.

She is a certified executive coach since 2011 with the accredited program with International Coach Federation (ICF) and also certified with psychometrics & diagnostic tools such as Hogan, MBTI, EQi 2.0, Leadership Potential by Korn Ferry. Ellen is passionate in building the culture of diversity and inclusion, and has invested her personal time in the past few years on female talents growth and career coaching.

In Ellen’s current role as HR Director of Asia Research & Development at Microsoft, she is responsible of driving strategic clarity and alignment through partnership and consultation with business leaders to deliver value and impact from people and organization perspectives.

Prior to Microsoft, Ellen was the Sr. Director of Leadership & Talent Management at AIA Insurance Co. China orchestrating the company’s long term learning strategy with holistic development framework to enable business to achieve growth aspiration plan in China. Before that, Ellen has held various senior HR leadership positions at Standard Chartered Bank both in China and Singapore for seven years with client facing and center of excellence roles looking after learning for global functions, learning for ASEAN region and also overall HR management for Retail Banking Business in China.

Between 2006-2012, Ellen was with Microsoft both in Taiwan and Greater China Region as the subsidiary HR lead for Taiwan and the People and Organization Capability Consultant in the region. Before that, she has diverse cross-cultural and industry experience travelling around in Asia, America and Europe in other multinational companies headquartered in US, Switzerland, Taiwan including airline services, tele-communication, high technology both hardware and software, distribution, sales & marketing and services with various roles in business planning and support, project management, Human Resources management.